Application of CT-Linac-Based All-in-One One-Stop Radiotherapy in All-Scenario Breast Cancer Radiotherapy: A Prospective Clinical Study
This study aims to evaluate and report the clinical adverse events and dosimetric parameters in breast cancer patients undergoing an all-in-one (AIO) one-stop, fully automated radiotherapy workflow. By systematically tracking these clinical and physical metrics, we seek to establish a standardized clinical protocol for AIO radiotherapy in breast cancer management.
• Histologically or pathologically confirmed breast cancer with definitive indications for radiotherapy (preoperative, postoperative, or radical)
• ECOG performance status of 0-2
• Able to remain still and supine on the treatment couch for up to 30 minutes
• Provision of signed, written informed consent
• Able to comply with daily follow-ups and blood sample collections